Corbus Pharmaceuticals Holdings (CRBP) Times Interest Earned (2013 - 2025)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Times Interest Earned came in at $0.55 in Q1 2025, down 54.87% year-on-year from $1.23 in Q1 2024, and up 102.24% quarter-over-quarter from -$24.72 in Q4 2024.
Corbus Pharmaceuticals Holdings (CRBP) Times Interest Earned (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Times Interest Earned history runs 13 years deep, the most recent figure standing at $0.55 for Q1 2025.
- On a quarterly basis, Times Interest Earned fell 54.87% year-over-year to $0.55 in Q1 2025; TTM through Sep 2025 was -$25.61, a 87.19% decrease from a year earlier, with the FY2024 full-year figure at $2.24, up 571.66% from the prior year.
- Times Interest Earned rose to $0.55 in Q1 2025 per CRBP's latest filing, from -$24.72 in the prior quarter.
- Across five years, Times Interest Earned topped out at $48.33 in Q4 2022 and bottomed at -$24.72 in Q4 2024.
- The 5-year median for Times Interest Earned is -$0.75 (2022), against an average of -$3.27.
- Biggest YoY gain for Times Interest Earned was 310.43% in 2022; the steepest drop was 2833.31% in 2022.
- Year by year, Times Interest Earned stood at -$22.97 in 2021, then soared by 310.43% to $48.33 in 2022, then plunged by 133.67% to -$16.27 in 2023, then sank by 51.94% to -$24.72 in 2024, then jumped by 102.24% to $0.55 in 2025.
- Per Business Quant, the three latest CRBP Times Interest Earned figures stand at $0.55 (Q1 2025), -$24.72 (Q4 2024), and -$5.96 (Q3 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 0.55 |
| Dec 31, 2024 | -24.72 |
| Sep 30, 2024 | -5.96 |
| Jun 30, 2024 | -0.90 |
| Mar 31, 2024 | 1.23 |
| Dec 31, 2023 | -16.27 |
| Sep 30, 2023 | -0.46 |
| Jun 30, 2023 | -0.39 |
| Mar 31, 2023 | -18.46 |
| Dec 31, 2022 | 48.33 |
| Sep 30, 2022 | -0.75 |
| Jun 30, 2022 | -1.14 |
| Mar 31, 2022 | -12.45 |
| Dec 31, 2021 | -22.97 |
| Sep 30, 2021 | -0.36 |
| Jun 30, 2021 | -0.45 |
| Mar 31, 2021 | -0.42 |
| Dec 31, 2020 | -123.04 |
| Sep 30, 2020 | -0.99 |
| Jun 30, 2020 | -1.22 |